Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

Analyst Ratings

5 Analysts Have This to Say About AerSale

By Benzinga Insights

May 26, 3:02 PM

Over the past 3 months, 5 analysts have published their opinion on AerSale (NASDAQ:ASLE) stock. These analysts are…

ASLE

News
SEC

IMTE Receives Nasdaq Notice Regarding Minimum Bid Requirements

By Benzinga Newsdesk

November 3, 5:43 PM

Integrated Media Technology Limited (NASDAQ:IMTE) ("IMTE" or the "Company"), announces today that on November 2, 2022, the Company received a notification letter (the "Notification

IMTE

Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $12

By Benzinga Newsdesk

July 20, 7:55 AM

Barclays analyst Steve Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $15 to $12.

GDRX

M&A Activity Slows In 2023 Despite Exxon, Chevron Mega Deals: Brighter Prospects In 2024

By Neil Dennis

December 21, 11:42 AM

Global M&A activity fell to worst levels in a decade in 2023, but some mega-deals announced & experts anticipate improved 2024.

CVX

Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Related Posts

5 Analysts Have This to Say About AerSale

IMTE Receives Nasdaq Notice Regarding Minimum Bid Requirements

Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $12

M&A Activity Slows In 2023 Despite Exxon, Chevron Mega Deals: Brighter Prospects In 2024